Is it safe to color my hair during or after chemotherapy?

 

Q: My sister had the Whipple procedure last June and is now going through chemotherapy 1 day a week. Is it safe for me to give her hair a permanent wave?

Q: Now that I have finished chemo and am taking Herceptin®, my hair is growing back. Is it safe to start coloring my hair again?

A: Because chemotherapy may cause hair loss (either partial or total), you should not perm, dye, or straighten the remaining hair during treatment. These cosmetic processes stress the hair and skin with chemicals and give off fumes that can cause nausea, eye irritation, and other problems. Cutting your hair shorter may help it look more full, instead of having a perm. Use only gentle moisturizing shampoos, conditioners, and skin creams.

After treatment, your hair and scalp are still sensitive, so continue to use gentle hair products. If you’ve lost your hair, it may regrow in a different texture and body. Wait until your hair has regrown for about 6 months to see its new condition before considering coloring, perming, or straightening it again. Talk with your doctor before using any hair processing agent. This is particularly important if you are on continuing medication.

--Bernice Crook, RN, OCN

Find out tips on looking good while going through treatment.

Latest Cancer News
U.S. Study Confirms Effectiveness of Stereotactic Radiotherapy for Early-stage Lung Cancer

March 18, 2010 — Researchers affiliated with a Phase II North American multicenter study have reported that sterotactic radiotherapy for Stage TI-II non–small cell lung cancer (NSCLC) results in a three-year survival rate of 56% in medically inoperable patients. The details of this study were published in the March 17, 2010 issue of the Journal of the American Medical Association.

Combined Modality Therapy Preserves Bladder and Offers Long-term Survival in Invasive Bladder Cancer

March 18, 2010 — Combined modality therapy (CMT) preserves the bladder, achieves complete response (CR), and offers long-term survival in approximately 70% of patients with invasive bladder cancer, according to the results of a 15-year study presented at 2010 American Society of Clinical Oncology Genitourinary Symposium March 5-7 in San Francisco.

Low-income Women Experience Delayed Follow-up of Abnormal Mammograms

March 18, 2010 — Researchers affiliated with Harvard University and the National Breast and Cervical Cancer Early Detection Program (BCCEDP) have reported that there is a significant delay in follow-up diagnostic tests and treatment following a positive mammogram in one-third of low-income women participating in this program. The details of this study were published early online in the Archives of Internal Medicine on March 16, 2010.

Select news items provided by Reuters Health